nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—Ibuprofen—THBD—atherosclerosis	0.00947	0.418	CrCbGaD
Sotalol—Laryngospasm—Niacin—atherosclerosis	0.0068	0.00717	CcSEcCtD
Sotalol—Ibuprofen—PLAT—atherosclerosis	0.00649	0.286	CrCbGaD
Sotalol—Sleep disorder—Rosuvastatin—atherosclerosis	0.00585	0.00617	CcSEcCtD
Sotalol—Amnesia—Rosuvastatin—atherosclerosis	0.00539	0.00568	CcSEcCtD
Sotalol—Vascular purpura—Lovastatin—atherosclerosis	0.0048	0.00506	CcSEcCtD
Sotalol—Sleep disorder—Simvastatin—atherosclerosis	0.00464	0.00489	CcSEcCtD
Sotalol—Amnesia—Lovastatin—atherosclerosis	0.00457	0.00482	CcSEcCtD
Sotalol—Vascular purpura—Simvastatin—atherosclerosis	0.00449	0.00473	CcSEcCtD
Sotalol—Amnesia—Ezetimibe—atherosclerosis	0.00448	0.00473	CcSEcCtD
Sotalol—Purpura—Lovastatin—atherosclerosis	0.00445	0.0047	CcSEcCtD
Sotalol—Influenza—Rosuvastatin—atherosclerosis	0.00438	0.00462	CcSEcCtD
Sotalol—Pain in extremity—Lovastatin—atherosclerosis	0.00429	0.00453	CcSEcCtD
Sotalol—Amnesia—Simvastatin—atherosclerosis	0.00427	0.00451	CcSEcCtD
Sotalol—Pain in extremity—Ezetimibe—atherosclerosis	0.00421	0.00444	CcSEcCtD
Sotalol—Sleep disorder—Pravastatin—atherosclerosis	0.00419	0.00442	CcSEcCtD
Sotalol—Purpura—Simvastatin—atherosclerosis	0.00416	0.00439	CcSEcCtD
Sotalol—Vascular purpura—Pravastatin—atherosclerosis	0.00406	0.00428	CcSEcCtD
Sotalol—Depression—Rosuvastatin—atherosclerosis	0.00389	0.0041	CcSEcCtD
Sotalol—Cramp muscle—Lovastatin—atherosclerosis	0.00386	0.00408	CcSEcCtD
Sotalol—Amnesia—Pravastatin—atherosclerosis	0.00386	0.00407	CcSEcCtD
Sotalol—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00383	0.00403	CcSEcCtD
Sotalol—Cramp muscle—Ezetimibe—atherosclerosis	0.00379	0.004	CcSEcCtD
Sotalol—Purpura—Pravastatin—atherosclerosis	0.00377	0.00397	CcSEcCtD
Sotalol—Influenza—Lovastatin—atherosclerosis	0.00371	0.00391	CcSEcCtD
Sotalol—Eosinophilia—Lovastatin—atherosclerosis	0.00367	0.00387	CcSEcCtD
Sotalol—Influenza—Ezetimibe—atherosclerosis	0.00364	0.00384	CcSEcCtD
Sotalol—Cramp muscle—Simvastatin—atherosclerosis	0.00361	0.00381	CcSEcCtD
Sotalol—Eosinophilia—Ezetimibe—atherosclerosis	0.0036	0.0038	CcSEcCtD
Sotalol—Affect lability—Pravastatin—atherosclerosis	0.00357	0.00377	CcSEcCtD
Sotalol—Mood swings—Pravastatin—atherosclerosis	0.00344	0.00363	CcSEcCtD
Sotalol—Eosinophilia—Simvastatin—atherosclerosis	0.00343	0.00362	CcSEcCtD
Sotalol—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00339	0.00357	CcSEcCtD
Sotalol—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00338	0.00357	CcSEcCtD
Sotalol—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00332	0.0035	CcSEcCtD
Sotalol—Cramp muscle—Pravastatin—atherosclerosis	0.00327	0.00345	CcSEcCtD
Sotalol—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00324	0.00342	CcSEcCtD
Sotalol—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00322	0.0034	CcSEcCtD
Sotalol—Abdominal distension—Niacin—atherosclerosis	0.00321	0.00338	CcSEcCtD
Sotalol—Influenza—Niacin—atherosclerosis	0.00319	0.00336	CcSEcCtD
Sotalol—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00318	0.00335	CcSEcCtD
Sotalol—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00317	0.00334	CcSEcCtD
Sotalol—Abdominal distension—Pravastatin—atherosclerosis	0.00316	0.00333	CcSEcCtD
Sotalol—Influenza—Pravastatin—atherosclerosis	0.00314	0.00331	CcSEcCtD
Sotalol—Arrhythmia—Rosuvastatin—atherosclerosis	0.00313	0.0033	CcSEcCtD
Sotalol—Eosinophilia—Pravastatin—atherosclerosis	0.00311	0.00328	CcSEcCtD
Sotalol—Angina pectoris—Niacin—atherosclerosis	0.0031	0.00327	CcSEcCtD
Sotalol—Depression—Simvastatin—atherosclerosis	0.00308	0.00325	CcSEcCtD
Sotalol—Angina pectoris—Pravastatin—atherosclerosis	0.00306	0.00322	CcSEcCtD
Sotalol—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00303	0.0032	CcSEcCtD
Sotalol—Flatulence—Rosuvastatin—atherosclerosis	0.003	0.00317	CcSEcCtD
Sotalol—Ibuprofen—CXCL8—atherosclerosis	0.00299	0.132	CrCbGaD
Sotalol—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00292	0.00307	CcSEcCtD
Sotalol—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00286	0.00302	CcSEcCtD
Sotalol—Depression—Pravastatin—atherosclerosis	0.00279	0.00294	CcSEcCtD
Sotalol—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00276	0.00291	CcSEcCtD
Sotalol—Myocardial infarction—Pravastatin—atherosclerosis	0.00274	0.00289	CcSEcCtD
Sotalol—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00274	0.00289	CcSEcCtD
Sotalol—Cough—Rosuvastatin—atherosclerosis	0.00266	0.00281	CcSEcCtD
Sotalol—Angiopathy—Ezetimibe—atherosclerosis	0.00264	0.00279	CcSEcCtD
Sotalol—Alopecia—Lovastatin—atherosclerosis	0.00262	0.00277	CcSEcCtD
Sotalol—Myalgia—Rosuvastatin—atherosclerosis	0.0026	0.00274	CcSEcCtD
Sotalol—Alopecia—Ezetimibe—atherosclerosis	0.00257	0.00271	CcSEcCtD
Sotalol—Haemoglobin—Niacin—atherosclerosis	0.00256	0.0027	CcSEcCtD
Sotalol—Haemorrhage—Niacin—atherosclerosis	0.00255	0.00269	CcSEcCtD
Sotalol—Flatulence—Lovastatin—atherosclerosis	0.00255	0.00269	CcSEcCtD
Sotalol—Dysgeusia—Lovastatin—atherosclerosis	0.00253	0.00267	CcSEcCtD
Sotalol—Back pain—Lovastatin—atherosclerosis	0.0025	0.00264	CcSEcCtD
Sotalol—Flatulence—Ezetimibe—atherosclerosis	0.0025	0.00263	CcSEcCtD
Sotalol—Muscle spasms—Lovastatin—atherosclerosis	0.00248	0.00262	CcSEcCtD
Sotalol—Infection—Rosuvastatin—atherosclerosis	0.00247	0.00261	CcSEcCtD
Sotalol—Visual impairment—Niacin—atherosclerosis	0.00246	0.00259	CcSEcCtD
Sotalol—Alopecia—Simvastatin—atherosclerosis	0.00245	0.00259	CcSEcCtD
Sotalol—Back pain—Ezetimibe—atherosclerosis	0.00245	0.00259	CcSEcCtD
Sotalol—Muscle spasms—Ezetimibe—atherosclerosis	0.00244	0.00257	CcSEcCtD
Sotalol—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00244	0.00257	CcSEcCtD
Sotalol—Vision blurred—Lovastatin—atherosclerosis	0.00244	0.00257	CcSEcCtD
Sotalol—Visual impairment—Pravastatin—atherosclerosis	0.00242	0.00255	CcSEcCtD
Sotalol—Flatulence—Simvastatin—atherosclerosis	0.00238	0.00251	CcSEcCtD
Sotalol—Dysgeusia—Simvastatin—atherosclerosis	0.00237	0.0025	CcSEcCtD
Sotalol—Muscle spasms—Simvastatin—atherosclerosis	0.00232	0.00245	CcSEcCtD
Sotalol—Vertigo—Lovastatin—atherosclerosis	0.00232	0.00245	CcSEcCtD
Sotalol—Angiopathy—Niacin—atherosclerosis	0.00231	0.00244	CcSEcCtD
Sotalol—Leukopenia—Lovastatin—atherosclerosis	0.00231	0.00244	CcSEcCtD
Sotalol—Vision blurred—Simvastatin—atherosclerosis	0.00228	0.0024	CcSEcCtD
Sotalol—Arrhythmia—Niacin—atherosclerosis	0.00228	0.0024	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00227	0.00239	CcSEcCtD
Sotalol—Alopecia—Niacin—atherosclerosis	0.00225	0.00238	CcSEcCtD
Sotalol—Insomnia—Rosuvastatin—atherosclerosis	0.00225	0.00237	CcSEcCtD
Sotalol—Arrhythmia—Pravastatin—atherosclerosis	0.00224	0.00237	CcSEcCtD
Sotalol—Palpitations—Ezetimibe—atherosclerosis	0.00224	0.00236	CcSEcCtD
Sotalol—Paraesthesia—Rosuvastatin—atherosclerosis	0.00223	0.00236	CcSEcCtD
Sotalol—Alopecia—Pravastatin—atherosclerosis	0.00222	0.00234	CcSEcCtD
Sotalol—Cough—Ezetimibe—atherosclerosis	0.00221	0.00233	CcSEcCtD
Sotalol—Chest pain—Lovastatin—atherosclerosis	0.0022	0.00232	CcSEcCtD
Sotalol—Myalgia—Lovastatin—atherosclerosis	0.0022	0.00232	CcSEcCtD
Sotalol—Anxiety—Lovastatin—atherosclerosis	0.00219	0.00231	CcSEcCtD
Sotalol—Dyspepsia—Rosuvastatin—atherosclerosis	0.00219	0.00231	CcSEcCtD
Sotalol—Hypertension—Ezetimibe—atherosclerosis	0.00219	0.00231	CcSEcCtD
Sotalol—Flatulence—Niacin—atherosclerosis	0.00219	0.00231	CcSEcCtD
Sotalol—Vertigo—Simvastatin—atherosclerosis	0.00217	0.00229	CcSEcCtD
Sotalol—Leukopenia—Simvastatin—atherosclerosis	0.00216	0.00228	CcSEcCtD
Sotalol—Myalgia—Ezetimibe—atherosclerosis	0.00216	0.00228	CcSEcCtD
Sotalol—Chest pain—Ezetimibe—atherosclerosis	0.00216	0.00228	CcSEcCtD
Sotalol—Flatulence—Pravastatin—atherosclerosis	0.00215	0.00227	CcSEcCtD
Sotalol—Dysgeusia—Pravastatin—atherosclerosis	0.00214	0.00226	CcSEcCtD
Sotalol—Muscle spasms—Niacin—atherosclerosis	0.00213	0.00225	CcSEcCtD
Sotalol—Pain—Rosuvastatin—atherosclerosis	0.00213	0.00224	CcSEcCtD
Sotalol—Muscle spasms—Pravastatin—atherosclerosis	0.0021	0.00222	CcSEcCtD
Sotalol—Infection—Lovastatin—atherosclerosis	0.0021	0.00221	CcSEcCtD
Sotalol—Vision blurred—Niacin—atherosclerosis	0.00209	0.00221	CcSEcCtD
Sotalol—Ibuprofen—PPARG—atherosclerosis	0.00207	0.0911	CrCbGaD
Sotalol—Thrombocytopenia—Lovastatin—atherosclerosis	0.00207	0.00218	CcSEcCtD
Sotalol—Vision blurred—Pravastatin—atherosclerosis	0.00206	0.00217	CcSEcCtD
Sotalol—Myalgia—Simvastatin—atherosclerosis	0.00206	0.00217	CcSEcCtD
Sotalol—Chest pain—Simvastatin—atherosclerosis	0.00206	0.00217	CcSEcCtD
Sotalol—Infection—Ezetimibe—atherosclerosis	0.00206	0.00217	CcSEcCtD
Sotalol—Anxiety—Simvastatin—atherosclerosis	0.00205	0.00216	CcSEcCtD
Sotalol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00204	0.00215	CcSEcCtD
Sotalol—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00203	0.00214	CcSEcCtD
Sotalol—Vertigo—Niacin—atherosclerosis	0.00199	0.0021	CcSEcCtD
Sotalol—Syncope—Niacin—atherosclerosis	0.00199	0.0021	CcSEcCtD
Sotalol—Leukopenia—Niacin—atherosclerosis	0.00199	0.0021	CcSEcCtD
Sotalol—Oedema—Simvastatin—atherosclerosis	0.00197	0.00208	CcSEcCtD
Sotalol—Abdominal pain—Rosuvastatin—atherosclerosis	0.00197	0.00208	CcSEcCtD
Sotalol—Vertigo—Pravastatin—atherosclerosis	0.00196	0.00207	CcSEcCtD
Sotalol—Palpitations—Niacin—atherosclerosis	0.00196	0.00207	CcSEcCtD
Sotalol—Infection—Simvastatin—atherosclerosis	0.00196	0.00207	CcSEcCtD
Sotalol—Leukopenia—Pravastatin—atherosclerosis	0.00196	0.00206	CcSEcCtD
Sotalol—Loss of consciousness—Niacin—atherosclerosis	0.00195	0.00206	CcSEcCtD
Sotalol—Cough—Niacin—atherosclerosis	0.00194	0.00204	CcSEcCtD
Sotalol—Thrombocytopenia—Simvastatin—atherosclerosis	0.00193	0.00204	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00192	0.00203	CcSEcCtD
Sotalol—Insomnia—Lovastatin—atherosclerosis	0.00191	0.00201	CcSEcCtD
Sotalol—Cough—Pravastatin—atherosclerosis	0.00191	0.00201	CcSEcCtD
Sotalol—Paraesthesia—Lovastatin—atherosclerosis	0.00189	0.002	CcSEcCtD
Sotalol—Myalgia—Niacin—atherosclerosis	0.00189	0.00199	CcSEcCtD
Sotalol—Hypertension—Pravastatin—atherosclerosis	0.00189	0.00199	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00188	0.00199	CcSEcCtD
Sotalol—Dyspnoea—Lovastatin—atherosclerosis	0.00188	0.00198	CcSEcCtD
Sotalol—Insomnia—Ezetimibe—atherosclerosis	0.00187	0.00197	CcSEcCtD
Sotalol—Myalgia—Pravastatin—atherosclerosis	0.00186	0.00196	CcSEcCtD
Sotalol—Chest pain—Pravastatin—atherosclerosis	0.00186	0.00196	CcSEcCtD
Sotalol—Paraesthesia—Ezetimibe—atherosclerosis	0.00186	0.00196	CcSEcCtD
Sotalol—Dyspepsia—Lovastatin—atherosclerosis	0.00186	0.00196	CcSEcCtD
Sotalol—Anxiety—Pravastatin—atherosclerosis	0.00185	0.00196	CcSEcCtD
Sotalol—Dyspnoea—Ezetimibe—atherosclerosis	0.00184	0.00195	CcSEcCtD
Sotalol—Decreased appetite—Lovastatin—atherosclerosis	0.00183	0.00193	CcSEcCtD
Sotalol—Dyspepsia—Ezetimibe—atherosclerosis	0.00182	0.00192	CcSEcCtD
Sotalol—Fatigue—Lovastatin—atherosclerosis	0.00182	0.00192	CcSEcCtD
Sotalol—Oedema—Niacin—atherosclerosis	0.00181	0.00191	CcSEcCtD
Sotalol—Pain—Lovastatin—atherosclerosis	0.0018	0.0019	CcSEcCtD
Sotalol—Decreased appetite—Ezetimibe—atherosclerosis	0.0018	0.0019	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.0018	0.0019	CcSEcCtD
Sotalol—Asthenia—Rosuvastatin—atherosclerosis	0.00179	0.00188	CcSEcCtD
Sotalol—Insomnia—Simvastatin—atherosclerosis	0.00178	0.00188	CcSEcCtD
Sotalol—Oedema—Pravastatin—atherosclerosis	0.00178	0.00188	CcSEcCtD
Sotalol—Fatigue—Ezetimibe—atherosclerosis	0.00178	0.00188	CcSEcCtD
Sotalol—Shock—Niacin—atherosclerosis	0.00178	0.00188	CcSEcCtD
Sotalol—Infection—Pravastatin—atherosclerosis	0.00177	0.00187	CcSEcCtD
Sotalol—Paraesthesia—Simvastatin—atherosclerosis	0.00177	0.00187	CcSEcCtD
Sotalol—Pain—Ezetimibe—atherosclerosis	0.00177	0.00187	CcSEcCtD
Sotalol—Pruritus—Rosuvastatin—atherosclerosis	0.00176	0.00186	CcSEcCtD
Sotalol—Dyspnoea—Simvastatin—atherosclerosis	0.00176	0.00186	CcSEcCtD
Sotalol—Hyperhidrosis—Niacin—atherosclerosis	0.00175	0.00185	CcSEcCtD
Sotalol—Thrombocytopenia—Pravastatin—atherosclerosis	0.00175	0.00184	CcSEcCtD
Sotalol—Dyspepsia—Simvastatin—atherosclerosis	0.00174	0.00183	CcSEcCtD
Sotalol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00172	0.00182	CcSEcCtD
Sotalol—Hyperhidrosis—Pravastatin—atherosclerosis	0.00172	0.00182	CcSEcCtD
Sotalol—Decreased appetite—Simvastatin—atherosclerosis	0.00171	0.00181	CcSEcCtD
Sotalol—Diarrhoea—Rosuvastatin—atherosclerosis	0.0017	0.0018	CcSEcCtD
Sotalol—Fatigue—Simvastatin—atherosclerosis	0.0017	0.00179	CcSEcCtD
Sotalol—Hypotension—Niacin—atherosclerosis	0.00169	0.00179	CcSEcCtD
Sotalol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00169	0.00178	CcSEcCtD
Sotalol—Pain—Simvastatin—atherosclerosis	0.00169	0.00178	CcSEcCtD
Sotalol—Abdominal pain—Lovastatin—atherosclerosis	0.00167	0.00176	CcSEcCtD
Sotalol—Body temperature increased—Lovastatin—atherosclerosis	0.00167	0.00176	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00165	0.00174	CcSEcCtD
Sotalol—Dizziness—Rosuvastatin—atherosclerosis	0.00165	0.00174	CcSEcCtD
Sotalol—Insomnia—Niacin—atherosclerosis	0.00164	0.00173	CcSEcCtD
Sotalol—Abdominal pain—Ezetimibe—atherosclerosis	0.00164	0.00172	CcSEcCtD
Sotalol—Body temperature increased—Ezetimibe—atherosclerosis	0.00164	0.00172	CcSEcCtD
Sotalol—Paraesthesia—Niacin—atherosclerosis	0.00163	0.00172	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00163	0.00171	CcSEcCtD
Sotalol—Dyspnoea—Niacin—atherosclerosis	0.00162	0.0017	CcSEcCtD
Sotalol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00161	0.0017	CcSEcCtD
Sotalol—Insomnia—Pravastatin—atherosclerosis	0.00161	0.0017	CcSEcCtD
Sotalol—Somnolence—Niacin—atherosclerosis	0.00161	0.0017	CcSEcCtD
Sotalol—Paraesthesia—Pravastatin—atherosclerosis	0.0016	0.00169	CcSEcCtD
Sotalol—Dyspepsia—Niacin—atherosclerosis	0.00159	0.00168	CcSEcCtD
Sotalol—Dyspnoea—Pravastatin—atherosclerosis	0.00159	0.00168	CcSEcCtD
Sotalol—Decreased appetite—Niacin—atherosclerosis	0.00157	0.00166	CcSEcCtD
Sotalol—Dyspepsia—Pravastatin—atherosclerosis	0.00157	0.00166	CcSEcCtD
Sotalol—Rash—Rosuvastatin—atherosclerosis	0.00157	0.00166	CcSEcCtD
Sotalol—Dermatitis—Rosuvastatin—atherosclerosis	0.00157	0.00165	CcSEcCtD
Sotalol—Body temperature increased—Simvastatin—atherosclerosis	0.00156	0.00164	CcSEcCtD
Sotalol—Abdominal pain—Simvastatin—atherosclerosis	0.00156	0.00164	CcSEcCtD
Sotalol—Headache—Rosuvastatin—atherosclerosis	0.00156	0.00164	CcSEcCtD
Sotalol—Decreased appetite—Pravastatin—atherosclerosis	0.00155	0.00164	CcSEcCtD
Sotalol—Pain—Niacin—atherosclerosis	0.00155	0.00163	CcSEcCtD
Sotalol—Fatigue—Pravastatin—atherosclerosis	0.00154	0.00162	CcSEcCtD
Sotalol—Pain—Pravastatin—atherosclerosis	0.00153	0.00161	CcSEcCtD
Sotalol—Asthenia—Lovastatin—atherosclerosis	0.00151	0.0016	CcSEcCtD
Sotalol—Pruritus—Lovastatin—atherosclerosis	0.00149	0.00157	CcSEcCtD
Sotalol—Asthenia—Ezetimibe—atherosclerosis	0.00148	0.00157	CcSEcCtD
Sotalol—Gastrointestinal pain—Niacin—atherosclerosis	0.00148	0.00156	CcSEcCtD
Sotalol—Nausea—Rosuvastatin—atherosclerosis	0.00148	0.00156	CcSEcCtD
Sotalol—Pruritus—Ezetimibe—atherosclerosis	0.00146	0.00154	CcSEcCtD
Sotalol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00146	0.00154	CcSEcCtD
Sotalol—Diarrhoea—Lovastatin—atherosclerosis	0.00144	0.00152	CcSEcCtD
Sotalol—Body temperature increased—Niacin—atherosclerosis	0.00143	0.00151	CcSEcCtD
Sotalol—Abdominal pain—Niacin—atherosclerosis	0.00143	0.00151	CcSEcCtD
Sotalol—Asthenia—Simvastatin—atherosclerosis	0.00142	0.00149	CcSEcCtD
Sotalol—Diarrhoea—Ezetimibe—atherosclerosis	0.00142	0.00149	CcSEcCtD
Sotalol—Abdominal pain—Pravastatin—atherosclerosis	0.00141	0.00149	CcSEcCtD
Sotalol—Body temperature increased—Pravastatin—atherosclerosis	0.00141	0.00149	CcSEcCtD
Sotalol—Pruritus—Simvastatin—atherosclerosis	0.0014	0.00147	CcSEcCtD
Sotalol—Dizziness—Lovastatin—atherosclerosis	0.00139	0.00147	CcSEcCtD
Sotalol—Dizziness—Ezetimibe—atherosclerosis	0.00137	0.00144	CcSEcCtD
Sotalol—Diarrhoea—Simvastatin—atherosclerosis	0.00135	0.00142	CcSEcCtD
Sotalol—Vomiting—Lovastatin—atherosclerosis	0.00134	0.00141	CcSEcCtD
Sotalol—Rash—Lovastatin—atherosclerosis	0.00133	0.0014	CcSEcCtD
Sotalol—Dermatitis—Lovastatin—atherosclerosis	0.00133	0.0014	CcSEcCtD
Sotalol—Headache—Lovastatin—atherosclerosis	0.00132	0.00139	CcSEcCtD
Sotalol—Vomiting—Ezetimibe—atherosclerosis	0.00132	0.00139	CcSEcCtD
Sotalol—Dizziness—Simvastatin—atherosclerosis	0.0013	0.00138	CcSEcCtD
Sotalol—Rash—Ezetimibe—atherosclerosis	0.0013	0.00138	CcSEcCtD
Sotalol—Dermatitis—Ezetimibe—atherosclerosis	0.0013	0.00137	CcSEcCtD
Sotalol—Asthenia—Niacin—atherosclerosis	0.0013	0.00137	CcSEcCtD
Sotalol—Headache—Ezetimibe—atherosclerosis	0.0013	0.00137	CcSEcCtD
Sotalol—Pruritus—Niacin—atherosclerosis	0.00128	0.00135	CcSEcCtD
Sotalol—Asthenia—Pravastatin—atherosclerosis	0.00128	0.00135	CcSEcCtD
Sotalol—Pruritus—Pravastatin—atherosclerosis	0.00126	0.00133	CcSEcCtD
Sotalol—Vomiting—Simvastatin—atherosclerosis	0.00125	0.00132	CcSEcCtD
Sotalol—Nausea—Lovastatin—atherosclerosis	0.00125	0.00132	CcSEcCtD
Sotalol—Rash—Simvastatin—atherosclerosis	0.00124	0.00131	CcSEcCtD
Sotalol—Dermatitis—Simvastatin—atherosclerosis	0.00124	0.00131	CcSEcCtD
Sotalol—Diarrhoea—Niacin—atherosclerosis	0.00124	0.00131	CcSEcCtD
Sotalol—Headache—Simvastatin—atherosclerosis	0.00124	0.0013	CcSEcCtD
Sotalol—Nausea—Ezetimibe—atherosclerosis	0.00123	0.0013	CcSEcCtD
Sotalol—Diarrhoea—Pravastatin—atherosclerosis	0.00122	0.00129	CcSEcCtD
Sotalol—Dizziness—Niacin—atherosclerosis	0.0012	0.00126	CcSEcCtD
Sotalol—Dizziness—Pravastatin—atherosclerosis	0.00118	0.00124	CcSEcCtD
Sotalol—Nausea—Simvastatin—atherosclerosis	0.00117	0.00124	CcSEcCtD
Sotalol—Vomiting—Niacin—atherosclerosis	0.00115	0.00121	CcSEcCtD
Sotalol—Rash—Niacin—atherosclerosis	0.00114	0.0012	CcSEcCtD
Sotalol—Dermatitis—Niacin—atherosclerosis	0.00114	0.0012	CcSEcCtD
Sotalol—Headache—Niacin—atherosclerosis	0.00113	0.0012	CcSEcCtD
Sotalol—Vomiting—Pravastatin—atherosclerosis	0.00113	0.0012	CcSEcCtD
Sotalol—Rash—Pravastatin—atherosclerosis	0.00112	0.00119	CcSEcCtD
Sotalol—Dermatitis—Pravastatin—atherosclerosis	0.00112	0.00119	CcSEcCtD
Sotalol—Headache—Pravastatin—atherosclerosis	0.00112	0.00118	CcSEcCtD
Sotalol—Nausea—Niacin—atherosclerosis	0.00108	0.00113	CcSEcCtD
Sotalol—Nausea—Pravastatin—atherosclerosis	0.00106	0.00112	CcSEcCtD
Sotalol—Ibuprofen—PTGS2—atherosclerosis	0.000872	0.0385	CrCbGaD
Sotalol—Ibuprofen—ALB—atherosclerosis	0.000777	0.0343	CrCbGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000117	0.00398	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000116	0.00396	CbGpPWpGaD
Sotalol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000116	0.00395	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CNR2—atherosclerosis	0.000114	0.0039	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000114	0.0039	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000114	0.0039	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000114	0.00388	CbGpPWpGaD
Sotalol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000113	0.00387	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—HRH1—atherosclerosis	0.000112	0.00384	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CNR2—atherosclerosis	0.000112	0.00381	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000111	0.0038	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—HRH1—atherosclerosis	0.00011	0.00375	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000108	0.0037	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—HRH1—atherosclerosis	0.000102	0.00348	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—HRH1—atherosclerosis	9.97e-05	0.00341	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	9.97e-05	0.00341	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	9.91e-05	0.00339	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	9.81e-05	0.00335	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CCL3—atherosclerosis	9.81e-05	0.00335	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	9.75e-05	0.00333	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	9.69e-05	0.00331	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCL3—atherosclerosis	9.6e-05	0.00328	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CCR2—atherosclerosis	8.87e-05	0.00303	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—EDNRA—atherosclerosis	8.87e-05	0.00303	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCR2—atherosclerosis	8.68e-05	0.00297	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—EDNRA—atherosclerosis	8.68e-05	0.00297	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—GHRL—atherosclerosis	8.65e-05	0.00296	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—GHRL—atherosclerosis	8.46e-05	0.00289	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—TNF—atherosclerosis	8.41e-05	0.00287	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	8.4e-05	0.00287	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	8.33e-05	0.00285	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	8.22e-05	0.00281	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	8.15e-05	0.00279	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—KNG1—atherosclerosis	7.59e-05	0.00259	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—AGTR1—atherosclerosis	7.54e-05	0.00258	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—KNG1—atherosclerosis	7.42e-05	0.00254	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—AGTR1—atherosclerosis	7.38e-05	0.00252	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCL4—atherosclerosis	7.37e-05	0.00252	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—UTS2—atherosclerosis	7.23e-05	0.00247	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCL4—atherosclerosis	7.21e-05	0.00246	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—UTS2—atherosclerosis	7.08e-05	0.00242	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	6.97e-05	0.00238	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CASR—atherosclerosis	6.94e-05	0.00237	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	6.82e-05	0.00233	CbGpPWpGaD
Sotalol—KCNH2—SIDS Susceptibility Pathways—IL6—atherosclerosis	6.79e-05	0.00232	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CASR—atherosclerosis	6.78e-05	0.00232	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—UTS2—atherosclerosis	6.57e-05	0.00225	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CNR2—atherosclerosis	6.45e-05	0.0022	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	6.44e-05	0.0022	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—UTS2—atherosclerosis	6.43e-05	0.0022	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—EDN1—atherosclerosis	6.4e-05	0.00219	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CCL5—atherosclerosis	6.35e-05	0.00217	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CNR2—atherosclerosis	6.31e-05	0.00216	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	6.3e-05	0.00215	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CX3CR1—atherosclerosis	6.3e-05	0.00215	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CASR—atherosclerosis	6.3e-05	0.00215	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—EDN1—atherosclerosis	6.26e-05	0.00214	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCL5—atherosclerosis	6.21e-05	0.00212	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CX3CL1—atherosclerosis	6.18e-05	0.00211	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CASR—atherosclerosis	6.16e-05	0.00211	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CX3CR1—atherosclerosis	6.16e-05	0.00211	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CX3CL1—atherosclerosis	6.04e-05	0.00207	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HRH1—atherosclerosis	6.02e-05	0.00206	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HRH1—atherosclerosis	5.89e-05	0.00201	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CNR2—atherosclerosis	5.85e-05	0.002	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	5.74e-05	0.00196	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CNR2—atherosclerosis	5.73e-05	0.00196	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	5.62e-05	0.00192	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—AGT—atherosclerosis	5.31e-05	0.00181	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—AGT—atherosclerosis	5.19e-05	0.00178	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCL3—atherosclerosis	5.03e-05	0.00172	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—EDNRA—atherosclerosis	5.01e-05	0.00171	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CCR2—atherosclerosis	5.01e-05	0.00171	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCL3—atherosclerosis	4.93e-05	0.00168	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—F2—atherosclerosis	4.91e-05	0.00168	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CCR2—atherosclerosis	4.9e-05	0.00168	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—EDNRA—atherosclerosis	4.9e-05	0.00168	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—GHRL—atherosclerosis	4.89e-05	0.00167	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—F2—atherosclerosis	4.8e-05	0.00164	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—GHRL—atherosclerosis	4.78e-05	0.00163	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOA4—atherosclerosis	4.73e-05	0.00162	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOA4—atherosclerosis	4.62e-05	0.00158	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EDNRA—atherosclerosis	4.55e-05	0.00156	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCR2—atherosclerosis	4.55e-05	0.00156	CbGpPWpGaD
Sotalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	4.54e-05	0.00155	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCR2—atherosclerosis	4.45e-05	0.00152	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EDNRA—atherosclerosis	4.45e-05	0.00152	CbGpPWpGaD
Sotalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	4.44e-05	0.00152	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—GHRL—atherosclerosis	4.44e-05	0.00152	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CCL2—atherosclerosis	4.37e-05	0.00149	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL4—atherosclerosis	4.35e-05	0.00149	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—GHRL—atherosclerosis	4.34e-05	0.00148	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—KNG1—atherosclerosis	4.29e-05	0.00147	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	4.28e-05	0.00146	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AGTR1—atherosclerosis	4.26e-05	0.00146	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL4—atherosclerosis	4.26e-05	0.00146	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	4.2e-05	0.00143	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	4.17e-05	0.00143	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOA2—atherosclerosis	4.07e-05	0.00139	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOA2—atherosclerosis	3.98e-05	0.00136	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—KNG1—atherosclerosis	3.89e-05	0.00133	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—UTS2—atherosclerosis	3.88e-05	0.00133	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AGTR1—atherosclerosis	3.87e-05	0.00132	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	3.81e-05	0.0013	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—UTS2—atherosclerosis	3.8e-05	0.0013	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	3.79e-05	0.00129	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CX3CR1—atherosclerosis	3.72e-05	0.00127	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CASR—atherosclerosis	3.72e-05	0.00127	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	3.65e-05	0.00125	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	3.64e-05	0.00124	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CASR—atherosclerosis	3.64e-05	0.00124	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	3.61e-05	0.00124	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	3.59e-05	0.00123	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	3.57e-05	0.00122	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	3.54e-05	0.00121	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	3.51e-05	0.0012	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	3.46e-05	0.00118	CbGpPWpGaD
Sotalol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	3.46e-05	0.00118	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	3.45e-05	0.00118	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	3.41e-05	0.00117	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	3.38e-05	0.00116	CbGpPWpGaD
Sotalol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	3.38e-05	0.00116	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	3.38e-05	0.00115	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	3.34e-05	0.00114	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	3.28e-05	0.00112	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	3.26e-05	0.00111	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	3.21e-05	0.0011	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	3.19e-05	0.00109	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	3.1e-05	0.00106	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VWF—atherosclerosis	3.08e-05	0.00105	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	3.06e-05	0.00105	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	3.05e-05	0.00104	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	3.03e-05	0.00104	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VWF—atherosclerosis	3.02e-05	0.00103	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	3e-05	0.00103	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	3e-05	0.00102	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	2.98e-05	0.00102	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	2.97e-05	0.00102	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	2.93e-05	0.001	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	2.91e-05	0.000994	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	2.85e-05	0.000974	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	2.79e-05	0.000952	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	2.77e-05	0.000948	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	2.72e-05	0.000931	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	2.71e-05	0.000927	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	2.69e-05	0.000919	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	2.69e-05	0.000919	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	2.68e-05	0.000915	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	2.67e-05	0.000911	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	2.65e-05	0.000907	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	2.63e-05	0.000899	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	2.63e-05	0.000899	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	2.62e-05	0.000896	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	2.62e-05	0.000896	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	2.62e-05	0.000896	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	2.62e-05	0.000895	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	2.6e-05	0.000887	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	2.56e-05	0.000876	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	2.56e-05	0.000876	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	2.56e-05	0.000876	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—F2—atherosclerosis	2.52e-05	0.00086	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—F2—atherosclerosis	2.46e-05	0.000842	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	2.41e-05	0.000823	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	2.36e-05	0.000806	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	2.3e-05	0.000786	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	2.29e-05	0.000782	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	2.25e-05	0.000769	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	2.24e-05	0.000767	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	2.24e-05	0.000765	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PLG—atherosclerosis	2.23e-05	0.000762	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	2.19e-05	0.00075	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PLG—atherosclerosis	2.18e-05	0.000745	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	2.11e-05	0.000721	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	2.06e-05	0.000706	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	2.04e-05	0.000697	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	2.03e-05	0.000694	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	1.99e-05	0.000682	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	1.99e-05	0.000679	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOB—atherosclerosis	1.97e-05	0.000673	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	1.95e-05	0.000668	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	1.94e-05	0.000663	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOB—atherosclerosis	1.93e-05	0.000659	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	1.92e-05	0.000658	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	1.91e-05	0.000653	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	1.9e-05	0.000648	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	1.88e-05	0.000643	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LPL—atherosclerosis	1.88e-05	0.000643	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LPL—atherosclerosis	1.84e-05	0.000629	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	1.83e-05	0.000625	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	1.79e-05	0.000612	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	1.78e-05	0.000609	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	1.77e-05	0.000606	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	1.74e-05	0.000596	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	1.74e-05	0.000593	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	1.65e-05	0.000564	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	1.61e-05	0.000551	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AGT—atherosclerosis	1.61e-05	0.00055	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LEP—atherosclerosis	1.58e-05	0.000539	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOE—atherosclerosis	1.58e-05	0.000539	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AGT—atherosclerosis	1.57e-05	0.000538	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	1.56e-05	0.000534	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	1.56e-05	0.000533	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LEP—atherosclerosis	1.54e-05	0.000527	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOE—atherosclerosis	1.54e-05	0.000527	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	1.53e-05	0.000522	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	1.52e-05	0.000521	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	1.51e-05	0.000515	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—F2—atherosclerosis	1.49e-05	0.000508	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	1.47e-05	0.000503	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—F2—atherosclerosis	1.45e-05	0.000497	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	1.42e-05	0.000486	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	1.39e-05	0.000476	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	1.36e-05	0.000466	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—INS—atherosclerosis	1.35e-05	0.00046	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.33e-05	0.000456	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.33e-05	0.000453	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—INS—atherosclerosis	1.32e-05	0.00045	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	1.3e-05	0.000445	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	1.3e-05	0.000443	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	1.27e-05	0.000436	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	1.24e-05	0.000423	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	1.21e-05	0.000414	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	1.18e-05	0.000404	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	1.16e-05	0.000395	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	1.05e-05	0.000358	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	1.03e-05	0.00035	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	1.01e-05	0.000346	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	9.96e-06	0.000341	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	9.9e-06	0.000338	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	9.75e-06	0.000333	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	9.48e-06	0.000324	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	9.38e-06	0.000321	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	9.27e-06	0.000317	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	9.22e-06	0.000315	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	9.19e-06	0.000314	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	9.17e-06	0.000314	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	9.02e-06	0.000308	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	8.99e-06	0.000307	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	8.51e-06	0.000291	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	8.43e-06	0.000288	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	8.33e-06	0.000285	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	8.24e-06	0.000282	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	8.05e-06	0.000275	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	7.88e-06	0.000269	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	7.81e-06	0.000267	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	7.64e-06	0.000261	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL6—atherosclerosis	5.89e-06	0.000201	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL6—atherosclerosis	5.76e-06	0.000197	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	5.43e-06	0.000186	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	5.31e-06	0.000182	CbGpPWpGaD
